ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (NASDAQ: CLPT) is a commercial-stage medical device company that develops and commercializes integrated systems for minimally invasive neurosurgical procedures. Founded in 1998, the company operates through two integrated business components: medical devices for neurosurgical applications and… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What ClearPoint Neuro, Inc. does
In the company’s own words
ClearPoint Neuro, Inc. (NASDAQ: CLPT) is a commercial-stage medical device company that develops and commercializes integrated systems for minimally invasive neurosurgical procedures. Founded in 1998, the company operates through two integrated business components: medical devices for neurosurgical applications and partnerships in the biologics and drug delivery space.
The company's primary product, the ClearPoint system, is an integrated platform comprising hardware components, disposable components, and software that guides physicians in surgical planning, device alignment, navigation, and procedure monitoring. The ClearPoint system targets and guides the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. Originally designed for use in MRI settings, the platform has expanded to support operating room procedures through products including the SmartFrame Array Neuro Navigation System and the SmartFrame OR Stereotactic System. The company also commercializes the ClearPoint Prism Neuro Laser Therapy System for laser ablation applications.
In 2025, ClearPoint Neuro expanded its portfolio through the acquisition of IRRAS Holdings, Inc., adding the IRRAflow Active Fluid Exchange System to serve the neurocritical care market. The IRRAflow system integrates continuous irrigation, drainage, and real-time intracranial pressure monitoring for controlled intracranial fluid management in intensive care units and operating rooms.
The biologics and drug delivery segment provides consulting services and products to pharmaceutical and biotech companies developing gene and cell therapies for neurological conditions. The company maintains commercial relationships with over 60 pharma, biotech, academic, and contract research organization partners. In 2024, the FDA granted marketing authorization for the SmartFlow Neuro cannula for delivering gene therapy for AADC deficiency treatment.
ClearPoint Neuro's business model emphasizes recurring revenue from disposable components while strategically pricing reusable components to secure hospital installations. The company manufactures products at facilities in Carlsbad and San Diego, California, and maintains an intellectual property portfolio including over 130 issued patents. The company's website is www.clearpointneuro.com.
Company details
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments
- Headquarters
- SOLANA BEACH, CA
- Fiscal year end
- December
- CIK
- 1285550
- SIC
- 3841
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns ClearPoint Neuro, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · ClearPoint Neuro, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do ClearPoint Neuro, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of ClearPoint Neuro, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in ClearPoint Neuro, Inc.'s last four quarterly filings that the numbers alone won't show?”